Gong M, Luo C, Meng H, et al. Upregulated LINC00565 accelerates ovarian cancer progression by targeting GAS6. OncoTargets Ther. 2019;12:10011–10022.
Upon reviewing the article, the authors noticed an error in on page 10019, it should be presented as follows:
The authors confirm that all of the results and conclusions of the article remain unchanged. The authors apologize for this error.
Figure 5 LINC00565 regulates the tumor growth in vivo. (A) The growth of tumors from sh-LINC00565 group were markedly slower than these from sh-NC group. (B) The tumors dissected from sh-LINC00565 group node mice were lighter than the sh-NC group. (C) qRT-PCR verified that LINC00565 expression was lower in sh-LINC00565 group than that in sh-NC group. (D) Immunohistochemistry showed that PCNA, Ki-67, Cyclin D1, Cyclin E1 and CDK4 were markedly reduced in LINC00565 knockdown group compared with NC group, nevertheless, P16 and P21 showed the opposite effect. ***P < 0.001.
